Crossmark

Clinical efficacy of chemotherapy followed by allogeneic hematopoietic stem cell transplantation with continuous tyrosine kinase inhibitor administration in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a retrospective analysis

Crossref DOI link: https://doi.org/10.1186/s40001-026-04525-3

Published Online: 2026-05-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Xinnan

Sun, Qianqian

Zhou, Dong

Wang, Ying

Zhao, Yue

Ma, Liyuan

Yan, Jinsong
Funding

Funding for this research was provided by:

grants from the Dalian Life and Health Guiding Plan Project (No. 2024ZDJH01PT085)
License Information

Text and Data Mining valid from 2026-05-24

Accepted Manuscript valid from 2026-05-24
More Information

Article History

Received: 12 January 2026

Accepted: 23 April 2026

First Online: 24 May 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below